Skip to main content
If you want to participate in any present or future clinical studies, please get in touch with the study coordinator(s) to express your interest.
Ongoing clinical studies:
Efficacy and safety of autologous, mobilized, non-expanded CD133+ cells to treat patients with Asherman’s syndrome: a prospective, multicenter, phase I/II clinical trial
Know more
Molecular transcriptomics of the endometrium in patients with repeated implantation failure by RNA sequencing at the single cell level: a prospective case-control study
Know more
Decoding the endometrial niche of adenomyosis at single-cell resolution
Know more
Prospective multicenter national biomedical cohort study of patients with surgical indications of suspected ovarian cancer
Know more
Prospective clinical study for the implementation of a molecular screening for the early detection of preeclampsia in the first trimester of pregnancy
Know more
Lifelong obesity prevention through early risk factors identification, prognosis, and intervention
Know more
Observational, prospective pilot study for the detection of intrapartum vaginal Streptococcus agalactiae using the DETECTR method as a proof of concept for the development of a rapid diagnostic test for group B Streptococcus
Know more
Biometric study for human endometrial stem cell identification and demonstration of their regenerative capacity through organoids (in vitro) and xenografts (in vivo) development in a murine model
Know more
Prospective observational study for the isolation and characterization of the mitochondrial DNA content of extracellular vesicles secreted by the human endometrium into the endometrial fluid
Know more
If you are a healthcare professional interested in collaborating with us, please email info@carlossimonfoundation.com with your proposal. We would like to know more about how you could contribute to our work.
If you are interested in donating to support our research, please email info@carlossimonfoundation.com, and one of our representatives will respond to your inquiry promptly.
If you want to learn about any present or future clinical studies, please get in touch with the study coordinator(s) to express your interest.
Ongoing clinical studies:
Efficacy and safety of autologous, mobilized, non-expanded CD133+ cells to treat patients with Asherman’s syndrome: a prospective, multicenter, phase I/II clinical trial
Know more
Molecular transcriptomics of the endometrium in patients with repeated implantation failure by RNA sequencing at the single cell level: a prospective case-control study
Know more
Decoding the endometrial niche of adenomyosis at single-cell resolution
Know more
Prospective multicenter national biomedical cohort study of patients with surgical indications of suspected ovarian cancer
Know more
Prospective clinical study for the implementation of a molecular screening for the early detection of preeclampsia in the first trimester of pregnancy
Know more
Lifelong obesity prevention through early risk factors identification, prognosis, and intervention
Know more
Observational, prospective pilot study for the detection of intrapartum vaginal Streptococcus agalactiae using the DETECTR method as a proof of concept for the development of a rapid diagnostic test for group B Streptococcus
Know more
Biometric study for human endometrial stem cell identification and demonstration of their regenerative capacity through organoids (in vitro) and xenografts (in vivo) development in a murine model
Know more
Prospective observational study for the isolation and characterization of the mitochondrial DNA content of extracellular vesicles secreted by the human endometrium into the endometrial fluid
Know more
If you are a healthcare professional interested in collaborating with us, please email info@carlossimonfoundation.com with your proposal. We would like to know more about how you could contribute to our work.
If you are interested in donating to support our research, please email info@carlossimonfoundation.com, and one of our representatives will respond to your inquiry promptly.